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Abstract
CD40 is a costimulatory molecule linking innate and adaptive immune responses to bacterial stimuli,
as well as a critical regulator of functions of other costimulatory molecules. The mechanisms
regulating lipopolysaccharide (LPS)-induced CD40 expression have not been adequately
characterized in human monocytic cells. In this study we used a human monocytic cell line, THP-1,
to investigate the possible mechanisms of CD40 expression following LPS exposure. Exposure to
LPS resulted in a dose- and time-dependent increase in CD40 expression. Further studies using
immunoblotting and pharmacological inhibitors revealed that mitogen-activated protein kinases
(MAPKs) and NFκB were activated by LPS exposure and involved in LPS-induced CD40 expression.
Activation of MAPKs was not responsible for LPS-induced NFκB activation. TLR4 was expressed
on THP-1 cells and pretreatment of cells with a Toll-like receptor 4 (TLR4) neutralizing antibody
(HTA125) significantly blunted LPS-induced MAPK and NFκB activation and ensuing CD40
expression. Additional studies with murine macrophages expressing wild type and mutated TLR4
showed that TLR4 was implicated in LPS-induced ERK and NFκB activation, and CD40 expression.
Moreover, blockage of MAPK and NFκB activation inhibited LPS-induced TLR4 expression. In
summary, LPS-induced CD40 expression in monocytic cells involves MAPKs and NFκB.
Keywords
Lipopolysaccharide; CD40; Toll-like receptor; Mitogen-activated protein kinase
*Address correspondence to: Weidong Wu, Center for Environmental Medicine, Asthma and Lung Biology, University of North Carolina
at Chapel Hill, North Carolina 27599, Tel. 919 843-2714; Fax. 919 966-9863; E-mail: Weidong_Wu@med.unc.edu.
Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers
we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting
proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could
affect the content, and all legal disclaimers that apply to the journal pertain.
Abbreviations: LPS, lipopolysaccharide; ERK, extracellular signal-regulated kinase; PI3K, phosphatidylinositol 3-kinase; MAPKs,
mitogen-activated protein kinases; JNK, c-Jun NH2-terminal kinase; NFκB, nuclear factor κB; TLR, toll-like receptor; DC, dendritic
cell; MFI, mean fluorescence intensity; STAT, signal transducers and activators of transcription
NIH Public Access
Author Manuscript
Toxicol Appl Pharmacol. Author manuscript; available in PMC 2009 April 15.
Published in final edited form as:














CD40 is a 45–50 kDa cell surface receptor of 277 amino acids, which is a member of the tumor
necrosis factor (TNF) receptor superfamily. It was first identified and functionally
characterized on B lymphocytes. Recent studies have revealed that CD40 is also expressed on
other cell types, including monocytes, macrophages, fibroblasts, dendritic cells, endothelial
cells, carcinoma cells, and epithelial cells (Banchereau et al., 1994; van Kooten and
Banchereau, 1997). CD40 ligand (CD40L) is expressed mainly and transiently on activated
CD4+ T cells. Upon CD40-CD40L contact, upregulation of various cell surface molecules,
such as class II major histocompatibility complex (MHC), CD80, and CD86, as well as the
production of numerous cytokines and chemokines, such as interleukin-1 (IL-1), IL-6, IL-10,
TNFα, and macrophage inflammatory protein1 (MIP-1) and cytotoxic radicals ensue
(Schonbeck and Libby, 2001). The interaction between CD40 and CD40L promotes B-cell
growth, differentiation, and immunoglobulin class switching, and facilitates maturation of
dendritic cells and antigen-presentation (Banchereau et al., 1994; Van Kooten and Banchereau,
1996; van Kooten and Banchereau, 2000). CD40 expression on non-hematopoietic cells might
be relevant to inflammatory responses. In addition, both CD40 and CD40L have been detected
in a natural soluble form, and could act at distinct sites (Hock et al., 2006). CD40 has been
implicated in many human diseases, particularly inflammatory autoimmune diseases
(Benveniste et al., 2004 ; Park et al., 2007).
The CD40 gene is mapped to human chromosome 20q11–q13 and is expressed as a single 1.5-
kb mRNA species. Cytokines and environmental stimuli have been shown to induce CD40
expression in a variety of cell types (Becker and Soukup, 2003; He et al., 2007; Lee et al.,
2007; Miyazawa et al., 2007). Distinct transcription factors including signal transducers and
activators of transcription 1 (STAT1), Sp1, and nuclear factor κB (NFκB) and cis-elements
such as Ets and Gas elements have been reported to participate in the transcriptional regulation
of CD40 expression in murine macrophages and microglia (Nguyen and Benveniste, 2000;
Tone et al., 2002; Qin et al., 2005; Qin et al., 2006). Human and murine CD40 shares 62%
amino acid identity. LPS-induced expression of CD40 and other co-stimulatory molecules has
been detected on human monocyte-derived dendritic cells (Ardeshna et al., 2000; Nakahara
et al., 2004). Although the downstream signal transduction and function of CD40 has been
extensively studied in a variety of cell types, the upstream events that regulate CD40 gene
expression have been less examined in human monocytic cells. In this study, a human
monocytic cell line, THP-1, was used to examine the regulation of CD40 expression on LPS-
treated cells. Involvement of MAPKs and NFκB signaling pathways were examined in LPS-
induced CD40 expression. In addition, a TLR4 neutralizing antibody and TLR4-deficient
mouse macrophage cell lines were also employed to investigate the role TLR4 played in LPS-
induced CD40 expression. It was found that LPS-induced CD40 expression was regulated by
TLR4-mediated activation of MAPKs and NFκB. Moreover, activated MAPKs and NFκB
could further mediate TLR4 expression induced by LPS.
Methods
Materials and Reagents
LPS (Escherichia coli 0127:B8) was purchased from Sigma-Aldrich Co. (St. Louis, MO). SDS-
PAGE supplies such as molecular mass standards and buffers were from Bio-Rad (Richmond,
CA). The mouse antibodies CD40-Phycoerythrin (PE) and IgG1-PE were obtained from
Beckman Coulter-Immunotech (Marseille, France). Rat anti-mouse CD40, mouse anti-human
Toll-like receptor 4 (TLR4) antibodies and IgG2a were purchased from eBiosience (San Diego,
CA). Phospho-specific and pan antibodies against extracellular signal-regulated kinase (ERK),
c-Jun NH2-terminal kinase (JNK), p38, and IκBα antibodies were obtained from Cell Signaling
Technology (Beverly, MA).β-actin antibody was purchased from USBiological (Swampscott,
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MA). NFκB p65 and p52 supershift antibodies, TLR4 neutralizing antibody (HTA125),
horseradish peroxidase (HRP)-conjugated goat anti-rabbit or goat anti-mouse IgG were
obtained from Santa Cruz Biotechnology (Santa Cruz, CA). The ERK kinase inhibitor U0126,
the p38 kinase inhibitor SB203580, the JNK inhibitor SP600125, the proteasome inhibitor
MG132, and the NFκB activation inhibitor Bay 11–7082 were purchased from EMD
Biosciences (San Diego, CA).
Cell Culture
The human monocytic leukemia cell line THP-1 was purchased from ATCC (Rockville, USA).
THP-1 cells were cultured in RPMI 1640 medium (Invitrogen, Grand Island, NY) containing
10% fetal bovine serum and 100 µg/ml penicillin/streptomycin at 37 °C in 5% CO2. Cells were
incubated in ultra low attachment plates (Corning Inc., Corning, NY) for LPS stimulation
studies.
The murine macrophage cell lines HeNC2 expressing wild type TLR4, and the GG2EE
expressing mutated TLR4 (LPS-hyporesponsive) were kindly provided by Dr. Steven B. Mizel
(Wake Forest University, NC) (Mizel et al., 2003). Cells were incubated in RPMI 1640 medium
containing 10% fetal bovine serum and 100 µg/ml penicillin/streptomycin at 37 °C in 5%
CO2.
Immunoblotting
Cells with or without pretreatment of pharmacological inhibitors or neutralizing antibody were
treated with LPS, washed twice with cold phosphate-buffered saline (PBS), and then lysed in
RIPA buffer (1× PBS, 1% Nonidet P-40, 0.5% sodium deoxycholate, 0.1% SDS, and protease
inhibitors: 20 µg/ml leupeptin, 20 µg/ml aprotinin, 0.5 mM phenylmethylsulfonyl fluoride,
200 µM sodium orthovanadate, and 20 mM sodium fluoride). Supernatants of cell lysates were
subjected to SDS-PAGE, as described before (Wu et al., 2005). Proteins were transferred onto
nitrocellulose membrane. Membrane was blocked with 5% nonfat milk, washed briefly,
incubated with primary antibody at 4°C overnight, followed by incubating with corresponding
HRP-conjugated secondary antibody for 1 h at room temperature. Immunoblot images were
detected using chemiluminescence reagents and the Gene Gynome Imaging System (Syngene,
Frederick, MD).
Flow Cytometry
Cells with or without pretreatment of pharmacological inhibitors were stimulated with LPS for
24 h. Flow cytometry was performed with a FACSORT (Becton Dickinson, Miami, FL) by
using an Argon-ion laser (wavelength 488nm) (Alexis et al., 2005). The FACSORT was
calibrated with Calibrate beads before each use, and 10,000 events were counted for all sample
runs. PE-conjugated non-specific antibodies of the same isotype as the receptor antibodies were
used as controls to establish background fluorescence and non-specific antibody binding. The
(arithmetic) mean fluorescence intensity (MFI) of the cells stained with control antibody was
subtracted from the MFI of cells stained with receptor antibodies to provide a measure of
receptor-specific MFI. Relative cell size and density/granularity were quantified by analyzing
light-scatter properties using Cell Quest software (Becton Dickinson), namely forward scatter
for cell size and side scatter for density/granularity, and recording the mean fluorescence
intensities for each.
Extraction of Nuclear Proteins and Electrophoretic Mobility Shift Assay (EMSA)
THP-1 cells with or without pretreatment of pharmacological inhibitors were stimulated with
1000 ng/ml LPS for 1 h. 100 ng/ml TNFα was used as a positive control. Cell pellets were
washed twice with cold-PBS. Nuclear proteins were extracted with a Nuclear/Cytosol
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Fractionation kit (Biovision Inc., Mountain View, CA). EMSA assay was conducted using an
EMSA Gel-Shift kit (Panomics Inc., Fremont, CA) according to the manufacture’s instruction.
Briefly, nuclear proteins were incubated with 2 µl of 5×binding buffer, 1 µl of poly d(I-C) (1
µg/ml), 1 µl of cold unlabeled or biotin-labeled NFκB probe (10 ng/ml), and 5 µl of distilled
water at 18°C for 30 min. For gel supershift assay, 2 µl of concentrated p65 or p50 antibody
was added into the reaction mixture, respectively, and incubated at room temperature for 10
min. After mixed with 1 µl of loading dye, the samples were subjected to electrophoresis in
0.5×TBE buffer. The protein-oligos complexes were transferred onto nylon membrane. The
images were developed using the detection buffer and substrates provided by the manufacture,
and detected using chemiluminescence reagents and the Gene Gynome Imaging System as
described previously. The sequence of oligonucleotide probe for NFκB binding site is as
follows: 5'-AGTTGAGGGGACTTTCCCAGGC-3’.
Statistics
Differences in CD40 expression were evaluated using nonparametric paired t tests with the
overall α level set at 0.05. Data were presented as means ± SEMs unless otherwise noted.
Results
LPS Exposure Induced CD40 Expression on THP-1 Cells
In this study, we examined CD40 expression on human THP-1 cells exposed to LPS. Exposure
of THP-1 cells to 1000ng/ml LPS for 24 h did not result in significant alteration in cell viability,
as assessed by assay of lactate dehydrogenase (LDH) activity (Data not shown). As shown in
Figure 1A, LPS exposure (10–1000 ng/ml) induced a dose-dependent increase in CD40
expression at 24 h. At 1000 ng/ml, LPS stimulated CD40 expression in a time-dependent
fashion (Figure 1B). In summary, LPS challenge elevated CD40 expression on the surface of
THP-1 cells.
LPS Induced Phosphorylation of MAPKs in THP-1 Cells
To explore the mechanisms underlying LPS-induced CD40 expression, the involvement of
mitogen-activated protein kinases (MAPKs) including ERK, JNK, and p38 kinase were
investigated in this study. Activation of MAPKs occurs through phosphorylation of specific
residues of these kinases. To determine the activation of MAPKs in THP-1 cells,
phosphorylation of MAPKs was measured using phospho-specific antibodies. THP-1 cells
were treated with 1000 ng/ml LPS for 0, 30, 60, 120, and 240 min. Cell lysates were subjected
to immunoblotting. As shown in Figure 2, LPS induced a time-dependent phosphorylation of
ERK, JNK, and p38 kinase detectable as early as 30 min. LPS-induced JNK phosphorylation
decreased at 4 h exposure of LPS. In summary, LPS exposure activated all three MAPKs in
THP-1 cells.
Involvement of MAPKs in LPS-induced CD40 Expression
MAPKs play important roles in regulating gene expression and immunological responses (Su
and Karin, 1996). Involvement of MAPKs in downstream signals of CD40 activation has been
reported (van Kooten and Banchereau, 2000). In this study, we investigated whether activation
of MAPKs participated in regulation of LPS-induced CD40 expression. Thus, selective kinase
inhibitors including U0126, SP600125, and SB203580, which specifically inhibited ERK
kinase, JNK, and p38 kinase activities, respectively, were employed to pretreat THP-1 cells
prior to LPS stimulation (1000 ng/ml) for 24 h. In comparison to vehicle treatment (DMSO),
all three MAPK inhibitors blunted LPS-induced CD40 expression (Figure 3). Among them,
U0126 appeared to have a strongest inhibitory effect. In a whole, these data demonstrate that
ERK, JNK, and p38 kinase are involved in LPS-induced CD40 expression.
Wu et al. Page 4













Activation of NFκB Was Required for LPS-induced CD40 Expression
NFκB transcription factors are present in the cytoplasm in an inactive state, complexed with
inhibitory IκB proteins, which cover the nuclear localization structures of NFκB. The function
of NFκB is primarily regulated by IκB family members. Phosphorylation of cytoplasmic
IκBα at two conserved NH2-terminal serine residues (Ser32 and Ser36) and its subsequent
proteosomal degradation by the 26S proteasome allows NFκB nuclear translocation and
activation of NFκB-dependent transcriptional activity (Wang et al., 2002). To examine whether
NFκB was activated in THP-1 cells exposed to LPS, phosphorylation of IκBα and IκBα
degradation were determined. THP-1 cells were pretreated with the proteasome inhibitor
MG-132, which prevents IκBα degradation by the 26S proteasome and, thereby, permits the
accumulation of phosphorylated IκBα in stimulated cells (Wu et al., 2002). Pretreated THP-1
cells were stimulated with 1000 ng/ml LPS. Cytoplasmic protein fractions were separated by
SDS-PAGE and immunoblotted with a phospho-specific antibody against the Ser32-
phosphorylated form of IκBα. As shown in Figure 4A, LPS stimulation increased IκBα
phosphorylation. Consistently, IκBα degradation was observed within the same exposure
periods (Figure 4B). Therefore, these data suggested that LPS exposure induced NFκB
activation in THP-1 cells.
To further demonstrate whether NFκB activation was involved in LPS-induced CD40
expression on THP-1 cells, a potent NFκB activation inhibitor, Bay 11–7082, was employed
to pretreat cells prior to LPS treatment for 24 h as described previously (Shanmugam et al.,
2003). The cell viability following Bay 11–7082 treatment was determined by trypan blue dye
exclusion assay, which showed that more than 90% of THP-1 cells were viable. As shown in
Figure 4C, Bay 11–7082 significantly suppressed LPS-induced CD40 expression in a dose-
dependent fashion on THP-1 cells, implying that NFκB activation was involved in LPS-
induced CD40 expression.
Involvement of TLR4 in LPS-induced CD40 Expression
It’s well established that LPS exerts its biological effects mainly but not entirely through the
TLR4 complex and its co-receptors (Wong et al., 2000; Beutler, 2002). By means of flow
cytometry using anti-human TLR4 antibody, we measured TLR4 expression on THP-1 cells.
This study showed that in addition to constitutive expression TLR4 could also be induced by
LPS stimulation on THP-1 cells (Figure 5A). To examine the role of TLR4 in LPS-induced
CD40 expression, THP-1 cells were pre-incubated with 10 µg/ml of isotype IgG or HTA125,
a TLR4 neutralizing antibody (HTA125), for 2 h prior to LPS treatment for 24 h. As shown in
Figure 5B, HTA125 partially but significantly blunted LPS-induced CD40 expression. These
data suggested that TLR4 mediated LPS-induced CD40 expression on THP-1 cells. Since
HTA125 is a weak TLR4 neutralizing antibody (Wang et al., 2003), we next utilized two mouse
macrophage cell lines, namely HeNC2 and GG2EE, to further define the involvement of TLR4
in LPS-induced CD40 expression. HeNC2 cells express wild-type TLR4 whereas GG2EE cells
express mutated TLR4 that is functionally inactive. As shown in Figure 5C, LPS induced a
dose-dependent increase in CD40 expression on both cell lines, but expression was
significantly reduced in GG2EE versus HeNC2 cells. This line of evidence supported the notion
that TLR4 participated in LPS-induced CD40 expression.
MAPKs Were not Required for LPS-induced NFκB
Since both MAPKs and NFκB were implicated in LPS-induced CD40 expression on THP-1
cells, this study further examined the possible interaction between these two pathways. Kinase
activity inhibitors were administered to evaluate their effect on LPS-induced IκBα degradation
and nuclear NFκB-DNA binding in THP-1 cells. As expected, in DMSO (vehicle)-pretreated
cells, LPS induced a marked reduction of IκBα, but inhibitors for ERK kinase, JNK, and p38
kinase had minimal effect on LPS-induced IκBα degradation (Figure 6A). To further verify
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this observation, a gel shift assay was performed to examine the effect of kinase inhibitors on
LPS-induced NFκB-DNA binding. As expected, the positive control, TNFα (100ng/ml),
induced a pronounced increase in NFκB-DNA binding (Figure 6B). Consistently, all three
MAPK inhibitors had minimal effect on LPS-induced NFκB-DNA binding. These data
demonstrated that MAPKs were not responsible for LPS-induced NFκB activation in THP-1
cells.
Interaction between TLR4 and MAPKs or NF.B in LPS-treated THP-1 cells
To examine the interaction between TLR4 and MAPKs or TLR4 and NFκB, THP-1 cells were
pre-incubated with 10 µg/ml of isotype IgG or HTA125 for 2 h prior to 1000 ng/ml LPS
treatment for 30 min. As shown in Figure 7, HTA125 blunted LPS-induced phosphorylation
of ERK (Figure 7A), JNK (Figure 7B), and p38 (Figure 7C), and degradation of IκBα (Figure
7D), respectively. In addition, ERK phosphorylation and IκBα degradation were also examined
in HeNC2 and GG2EE cells exposed to LPS. In consistent with the findings from THP-1 cells,
LPS stimulation induced more pronounced phosphorylation of ERK and degradation of
IκBα in HeNC2 cells than in GG2EE cells (Figure 7E and 7F). These results indicated that
TLR4 was required for LPS-induced MAPK and NFκB activation. Furthermore, we
investigated the effects of MAPKs and NFκB on LPS-induced TLR4 expression. Pretreatment
of THP-1 cells with DMSO, MAPK or NFκB inhibitors significantly inhibited LPS-induced
TLR4 expression (Figure 8), respectively. Therefore, these data suggested that interaction
between TLR4 and MAPKs or NFκB participated in LPS-induced CD40 expression.
Discussion
Downstream signaling of CD40 ligation has been well characterized, which may involve TNF
receptor associated factors (TRAF), NFκB, MAPKs, phophoinositide-3 kinase (PI3K),
phospholipase C (PLC), and STAT3 and 6 (van Kooten and Banchereau, 2000). This study
using human monocytic cells demonstrated that MAPKs and NFκB could also participate in
the upstream events regulating LPS-induced CD40 gene expression.
The mitogen-activated protein kinases (MAPKs) are generally expressed in all cell types. LPS
is a potent activator of all three MAPKs (Sweet and Hume, 1996). Previous studies have
demonstrated that MAPK-mediated LPS effects were cell type specific and depended on the
surface molecules studied. For example, both JNK and p38, but not ERK, were found to mediate
LPS-induced up-regulation of CD80, CD83, CD86, and CD54, but not that of HLA-DR in
human dendritic cells (Nakahara et al., 2004). JNK, but not p38 and ERK, was found to involve
in LPS-induced B7.1, IL-10 or CD44 expression in THP-1 cells (Ma et al., 2001; Gee et al.,
2002; Lim et al., 2005). Inconsistent effects of MAPKs on LPS-induced surface marker
expression have been observed. For example, one study demonstrated that p38 kinase was
required for LPS-induced upregulation of CD80, CD83, and CD86, but did not have any
significant effect on the LPS-induced changes in HLA-DR, CD40, and CD1a expression in
human monocyte-derived dendritic cells (Ardeshna et al., 2000). The other study showed that
p38, but not ERK, was involved in LPS- and TNFα-induced upregulation of CD1a, CD40, and
HLA-DR in the maturation of CD83− dendritic cells derived from human blood monocytes
(Arrighi et al., 2001). In contrast, our study with three kinase-specific inhibitors demonstrated
that all three MAPKs including ERK, JNK, and p38 kinase were involved in LPS-induced
CD40 expression on THP-1 cells. It is not possible to make quantitative inferences regarding
the relative involvement of MAPKs based solely on the efficacy of the different MAPK
inhibitors in blocking CD40 expression. However, our finding that each of the inhibitors
partially blocked CD40 expression induced by LPS implied a complex regulatory mechanism
that included all of the MAPK intermediates examined. Furthermore, differential involvement
of MAPKs has also been observed in human dendritic cell maturation and Th1/Th2 engagement
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(Nakahara et al., 2006). In addition to MAPKs, NFκB was also shown to play a critical role in
LPS-induced CD40 expression since inhibition of NFκB activation with Bay 11–7082
significantly blocked CD40 expression on THP-1 cells exposed to LPS. Distinct roles for the
five NFκB molecules including p50, p52, RelA (p65), c-Rel, and RelB have been identified in
dendritic cell function (Berges et al., 2005). In this study we observed that p65 was mainly
affected by LPS exposure in THP-1 cells using the supershift assay.
Both MAPKs and NFκB were shown to participate in LPS-induced CD40 expression in this
study. However, the mechanisms responsible for MAPK-mediated CD40 transcription or LPS-
induced NFκB activation remained elusive. NFκB has been proposed as an important
transcription factor in LPS-induced CD40 expression in murine macrophages (Qin et al.,
2005). Analysis of the CD40 promoter demonstrates that NFκB regulatory elements is
conserved between the human and mouse CD40 promoters. Within the CD40 promoter, there
are four NFκB sites that are designated as dκB, mκB, m2κB, and pκB (Nguyen and Benveniste,
2002). In this study, LPS exposure was found to activate the NFκB signaling pathway,
including IκBα phosphorylation, degradation, and NFκB-DNA binding in THP-1 cells. Recent
studies have investigated the upstream signaling pathways responsible for LPS-induced
NFκB activation. It was shown that LPS could induce NFκB activation through transforming
growth factor β (TGFβ)–activated kinase (TAK1), which was a member of the mitogen-
activated protein kinase kinase kinase (MAPKKK) family (Akira and Takeda, 2004). PI3K
was also demonstrated to mediate LPS-induced NFκB activation through induction of p65
phosphorylation (Guha and Mackman, 2001). Although MAPKs were activated by LPS
exposure in this study, inhibition of MAPKs with specific kinase inhibitors did not block LPS-
induced IκBα degradation and NFκB-DNA binding, implying that these kinases were not
involved in LPS-induced NFκB activation. Few studies have explored the signaling events that
mediated MAPK-related CD40 transcription. MAPK pathways control gene expression in a
number of ways including the phosphorylation and regulation of transcription factors, co-
regulatory proteins and chromatin proteins (Whitmarsh, 2006). As described earlier, MAPKs
had little effect on LPS-induced NFκB activation. Thus, MAPKs might regulate CD40
expression through other transcription factors, such as STAT1. STAT1 has been reported to
regulate CD40 expression through the Gas element in the CD40 promoter ( Lee et al., 2007;
Qin et al., 2005). Previous studies have shown that p38 MAPK, but not ERK, was involved in
plasmin-triggered DNA binding of STAT1 and subsequent expression of CD40 in human
primary monocytes (Burysek et al., 2002). Pretreatment of mouse microglia cells with selective
antagonists of ERK1/2 and p38 MAPK counteracted guanosine inhibition on cytokine-induced
CD40 expression and function as well as on STAT1 nuclear translocation (D'Alimonte et al.,
2007).
Analysis of the time course of LPS-induced CD40 expression on THP-1 cells revealed that
upregulation of CD40 expression occurred 8 h following LPS treatment in this study. This
latent process of CD40 expression may involve autocrine stimulation of cytokine production.
LPS stimulation has been shown to induce expression of cytokines and chemokines in THP-1
cells or murine macrophages (Glue et al., 2002; Harrison et al., 2004; Harrison et al., 2005;
Qin et al., 2005). These cytokines or chemokines may modulate LPS-induced CD40 expression
on THP-1 cells as on other cell types (Nguyen et al., 2000; Nguyen et al., 2002; Qin et al.,
2005). We speculate that MAPKs and NFκB activation induced by LPS is associated with the
expression and feedback action of these cytokines. On the one hand, MAPKs and NFκB could
regulate expression of these cytokines; on the other hand, these cytokines may modulate CD40
expression via activating MAPKs and NFκB (Lim et al., 2002; Gee et al., 2003; Ma et al.,
2004; Lim et al., 2005). In addition, the effect of cytokines on MAPKs and NFκB could be
interrelated or independent. Such a scenario could explain the lack of inhibition of NFκB
activation by inhibiting MAPKs.
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LPS is the major component of the outer membrane of Gram-negative bacteria. The immune
response to microbial pathogens relies on both innate and acquired immunity. Innate immunity
is determined by the interaction between potential pathogens and their cognate binding
receptors, including the Toll-like receptor (TLR) family (Akira and Takeda, 2004; Beutler,
2004). At least 10 TLRs (TLR1-TLR10) recognize specific molecular patterns that are present
in microbial components. Stimulation of different TLRs induces distinct patterns of gene
expression, which not only leads to the activation of innate immunity but also instructs the
development of antigen-specific acquired immunity. TLR4 has now been established as the
main transmembrane receptor for LPS although it also recognizes other biological components
(Poltorak et al., 1998; Takeuchi and Akira, 2001; Palsson-McDermott and O'Neill, 2004). In
this study, we observed that TLR4 was constitutively expressed and could also be induced by
LPS exposure on THP-1 cells. Pretreatment of THP-1 cells with the TLR4 neutralizing
antibody HTA125 blunted LPS-induced CD40 expression, implying that TLR4 mediated LPS-
induced CD40 expression on THP-1 cells. This notion was further strengthened by the studies
using murine macrophage cell lines, which showed that GG2EE cells expressing a functionally
mutated TLR4, presented impaired CD40 expression as compared to HeNC2 cells with
functional TLR4. It has recently been proposed that TLR4 uses two different signaling
pathways, the MyD88-dependent and –independent pathways, to lead to NFκB activation. The
former involves the adaptor proteins MyD88 and Mal/TIRAP pathway with direct NFκB
activation, and the latter involves the adaptor proteins TRIF and TRAM pathway with late
NFκB activation (Yamamoto et al., 2003a; Yamamoto et al., 2003b). Our studies suggested
that TLR4-mediated CD40 expression operated mainly through a TLR4-MyD88-dependent
pathway in LPS-treated THP-1 cells. First, NFκB was rapidly activated by LPS stimulation.
Second, GG2EE cells expressing mutated nonfunctional TLR4 (P712H) demonstrated reduced
levels of CD40 expression than HeNC2 cells expressing wild-type functional TLR4. TLR4
(P712H) was incapable of interaction with MyD88 (Rhee and Hwang, 2000). The fact that
CD40 expression was partially inhibited by HTA125 and GG2EE cells expressed reduced
CD40 suggested that TLR4-independent mechanisms might also play some role in LPS-
induced CD40 expression (Triantafilou et al., 2001). Interestingly, in addition to acting as the
downstream effector of TLR4 activation, MAPKs and NFκB were also shown to regulate TLR4
expression. The interaction between TLR4 and MAPKs or NFκB might strengthen LPS-
induced CD40 expression on THP-1 cells.
CD40-CD154 has emerged as a key signaling pathway for the function of B cells, monocytes,
and dendritic cells (DC) in the immune system. LPS as it relates to CD40 expression, promotes
maturation of immature myeloid DCs and naïve monocytes to mature DCs. Therefore,
understanding the mechanisms underlying LPS-induced CD40 expression in immune cells will
provide fundamental information for more precise control over communication between innate
and adaptive immune responses in diverse diseases.
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LPS exposure results in increase in CD40 expression on THP-1 cells. A, THP-1 cells were
exposed to 0–1000 ng/ml of LPS for 24 h. B, THP-1 cells were exposed to 1000 ng/ml of LPS
for 2, 4, 8, and 24 h. CD40 expression was measured with flow cytometry using isotype and
anti-CD40 antibodies, respectively, as described in Materials and Methods.
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LPS induces phosphorylation of MAPKs in THP-1 cells. THP-1 cells were exposed to 1000
ng/ml of LPS for 0, 30, 60, 120, and 240 min. Cells were lysed with RIPA buffer. Supernatants
of cell lysates were subjected to SDS-PAGE and immunoblotting. Phosphorylated ERK (A),
JNK (B), and p38 kinase (C) were detected using phospho-specific antibodies. Data shown are
representative of three separate experiments.
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MAPK inhibitors inhibit LPS-induced CD40 expression on THP-1 cells. THP-1 cells were
pretreated with DMSO, 20 µM U0126, 20 µM SP600125, or 20 µM SB203580 for 30 min,
respectively, prior to 1000 ng/ml LPS treatment for 24 h. CD40 expression was determined
using flow cytometry. * P<0.05, compared to vehicle (DMSO) LPS.
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NFκB activation is required for LPS-induced CD40 expression on human THP-1 cells. A,
THP-1 cells were pretreated with 20 µM MG-125 for 30 min , then incubated with 1000 ng/
ml LPS for 0, 30, 60, 120, and 240 min. Cells were lysed with RIPA buffer. Cell lysates were
subjected to SDS-PAGE and immunoblotting. Phosphorylated IκBa was detected using
phospho-specific anti-IκBα antibody. B, THP-1 cells without MG-125 pretreatment were
incubated with 1000 ng/ml LPS for 0, 30, 60, 120, and 240 min. IκBα and actin protein levels
were measured as described above. C, THP-1 cells were pretreated with DMSO, 5 µM or 10
µM Bay 11–7082 for 30 min prior to 1000 ng/ml LPS stimulation for 24 h, respectively. CD40
expression (MFI) was measured with flow cytometry. * P<0.05, compared to vehicle (DMSO)
LPS.
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TLR4 is involved in LPS-induced CD40 expression. A, THP-1 cells were treated with 1000
ng/ml LPS or control (PBS) for 4 h and 24 h. TLR4 was determined with flow cytometry using
anti-TLR4 antibody (*P<0.05 vs. control, 24 h). B, THP-1 cells were pretreated with HTA125
(10 µg/ml) or isotype IgG for 2 h prior to LPS (1000 ng/ml) treatment for 24 h. CD40 expression
(MFI) was measured with flow cytometry (*P<0.05 vs. vehicle LPS). C, Mouse macrophage
cell lines HeNC2 and GG2EE were treated with 0.01, 1, 100, and 1000 ng/ml of LPS for 24 h.
CD40 expression was measured with flow cytometry (* P<0.05, compared to GG2EE).
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MAPKs are not required for LPS-induced NFκB activation. THP-1 cells were pretreated with
DMSO (vehicle), 20 µM U0126, 20 µM SP600125, or 20 µM SB203580 for 30 min,
respectively, prior to 1000 ng/ml LPS treatment for 60 min. A, IκBα and actin protein levels
were measured with immunoblotting using anti-IκBα and anti-actin antibodies. B, NFκB-DNA
binding was detected using a gel shift kit following the manufacture’s instruction. A supershift
assay was conducted using concentrated anti-p65 and anti-p50 antibodies.
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TLR4 is involved in LPS-induced MAPK and NFκB activation. THP-1 cells were pretreated
with HTA125 (10 µg/ml) or isotype IgG for 2 h prior to LPS (1000 ng/ml) treatment for 30
min. Phosphorylation of ERK (A), JNK (B), p38 (C), and IκBα protein levels (D) were
determined with immunoblotting as described previously. Mouse macrophage cell lines
HeNC2 and GG2EE were treated with 1000 ng/ml LPS for 30 min. Phosphorylation of ERK
and IκBα protein levels (E and F) were measured with immunoblotting.
Wu et al. Page 18














MAPKs and NFκB are involved in LPS-induced TLR4 expression on THP-1 cells. THP-1 cells
were pretreated with DMSO (vehicle), 20 µM U0126, 20 µM SP600125, 20 µM SB203580,
or 10 µM Bay 11–7082 for 30 min, respectively, prior to 1000 ng/ml LPS treatment for 24 h.
TLR4 expression was determined using flow cytometry. Levels of TLR4 expression induced
by LPS were expressed as fold over control. * P<0.05, compared to vehicle (DMSO) LPS.
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